Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
J Gastrointest Surg. 2013 Jun;17(6):1098-106. doi: 10.1007/s11605-013-2181-x. Epub 2013 Apr 4.
High-resolution, multiphase, computed tomography (CT) is a standard preoperative test prior to pancreatectomy, yet the clinical significance of routinely reported findings remains unknown.
We identified patients who underwent a pancreaticoduodenectomy for a periampullary adenocarcinoma (PA) over the previous 5 years and had a pancreas protocol CT at our institution. Clinicopathologic implications of reported CT findings were evaluated.
There were 155 pancreatic ductal adenocarcinomas (PDA) and 47 non-pancreatic PAs. No mass was visualized on CT in 6 % of PDAs and 23 % of non-pancreatic PA. A size discrepancy of ≥1 cm between radiographic and pathologic tumor diameters was observed in 40 % of PAs, with CT underestimating the size in most instances (75 %). Radiographically enlarged lymph nodes were not associated with true lymph node metastases in PDAs (70 % lymph node positive cases were enlarged on CT vs 74 % lymph node negative, p = 0.5), but were associated with a preoperatively placed biliary endoprosthesis (63 % with endoprosthesis were enlarged vs 37 % no endoprosthesis, p = 0.013). Major visceral vessel involvement on CT was not associated with a vascular resection (3 % with CT vessel involvement vs 2 % without, p = 0.8) or a positive uncinate resection margin (24 vs 20 %, respectively, p = 0.6).
While dedicated pancreas protocol CT provides unprecedented detail, the test may lead to overinterpretation of the extent of disease in some instances. A radiographic suggestion of enlarged lymph nodes and vascular involvement does not necessarily preclude exploration with curative intent. CTs with local disease should be reported in an objective template and carefully reviewed by a multidisciplinary group of surgeons, radiologists, and oncologists to avoid missing an opportunity for neoadjuvant therapy or cure by resection.
高分辨率、多期、计算机断层扫描(CT)是胰十二指肠切除术之前的标准术前检查,但常规报告结果的临床意义尚不清楚。
我们在过去 5 年内确定了在我院行胰十二指肠切除术治疗壶腹周围腺癌(PA)的患者,并对其进行了胰腺协议 CT 检查。评估了报告 CT 结果的临床病理意义。
有 155 例胰腺导管腺癌(PDA)和 47 例非胰腺 PA。6%的 PDA 和 23%的非胰腺 PA 在 CT 上未发现肿块。40%的 PA 存在影像学与病理肿瘤直径差值≥1cm,且多数情况下 CT 低估了肿瘤大小(75%)。在 PDA 中,影像学上增大的淋巴结与真正的淋巴结转移无关(CT 阳性淋巴结转移病例中有 70%淋巴结增大,而 CT 阴性淋巴结转移病例中有 74%,p=0.5),但与术前放置的胆道支架有关(有支架的病例中有 63%淋巴结增大,无支架的病例中有 37%,p=0.013)。CT 上主要内脏血管受累与血管切除无关(CT 血管受累病例中有 3%进行了血管切除,而无 CT 血管受累病例中有 2%,p=0.8),也与阳性钩突切除边缘无关(分别为 24%和 20%,p=0.6)。
虽然专门的胰腺协议 CT 提供了前所未有的细节,但在某些情况下,该检查可能导致对疾病范围的过度解释。影像学上提示淋巴结肿大和血管受累并不一定排除以治愈为目的的探查。应使用客观模板报告局部疾病的 CT 结果,并由外科医生、放射科医生和肿瘤学家组成的多学科小组仔细审查,以避免错过新辅助治疗或通过切除治愈的机会。